Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2015 Jul;25(6):1015–1022. doi: 10.1097/IGC.0000000000000453

Table 1.

Demographic and Clinicopathologic Characteristics of Study Groups±

Normal Plt
(n=265)
Elevated Plt
(n=53)
P
N % N %
Age (years) 0.192
  Mean ± Standard deviation 64.2 ± 11.0 61.9 ± 10.0
Serum Platelet Level (K/ml) <0.0001
Mean ± Standard deviation 272.4 ± 63.4 487.2 ± 98.2
BMI (Kg/m2) 0.340
  Mean ± Standard deviation 32.7 ± 9.5 31.3 ± 8.5
CA-125 (U/ml) 0.320
  Mean ± Standard deviation 113.0 ± 387 159.5 ± 237
Race 0.192
  White 222 84.4 48 92.3
  Black/Other 41 15.6 4 7.7
FIGO Stage 0.044
  I–II 132 73.7 26 57.8
  III–IV 47 26.3 19 42.2
Grade 0.680
  1 43 18.0 7 14.6
  2–3 196 82.0 41 85.4
Radiation Treatment 0.879
  Yes 119 46.1 23 44.2
  No 139 53.9 29 55.8
LVSI 0.056
  Present 181 68.8 40 83.3
  Absent 82 31.2 8 16.7
Histology 0.273
  Endometrioid 92 35.0 23 43.4
  Non-Endometrioid* 173 65.0 30 56.6
±

Totals of each category of discrete variables may not equal 318 due to missing data. For continuous variables, there is no missing data for age or platelet level. For BMI, N=8 missing data, and for CA-125 N=88 for missing data.

Discrete variables were analyzed with Fisher’s exact contingency tables, continuous variables were analyzed with sample t-test

*

includes carcinosarcoma